[HTML][HTML] Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Methods Two hundred ninety-five subjects who received BNT162b2 or CoronaVac vaccines
from five vaccination centers were categorized into moderate/severe HS (controlled …
from five vaccination centers were categorized into moderate/severe HS (controlled …
[HTML][HTML] Not only high number and specific Comorbidities but also age are closely related to progression and poor prognosis in patients with COVID-19
D Liu, Y Zheng, J Kang, D Wang, L Bai, Y Mao… - Frontiers in …, 2022 - frontiersin.org
Background: Some patients with comorbidities and rapid disease progression have a poor
prognosis. Aim: We aimed to investigate the characteristics of comorbidities and their …
prognosis. Aim: We aimed to investigate the characteristics of comorbidities and their …